Purchase Order 75N92B24P00051
Award Date 12/15/23
Potential Completion Date 6/14/24
Potential Value $22K
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company, through its BDB Division operating as BD Biosciences, received a $24,942.30 firm fixed-price purchase order award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 23, 2025, with an ultimate completion date of December 22, 2026, will be performed in San Jose, California. This award was made on a full and open competition basis without a small...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $22,107.60 firm fixed-price purchase order by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 23, 2025, with an ultimate completion date of December 22, 2026. The contract was awarded without a set-aside designation and will be performed in San Jose, California. As a global medical technology manufacturer specializing in flow cytometry systems,...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a $22,613.40 firm fixed-price contract call under a Blanket Purchase Agreement by the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the provision of scientific instruments and related services. The contract, awarded on March 11, 2020, with an ultimate completion date of August 31, 2020, will support the institute's research operations at its Bethesda, Maryland facility. No small business...
- Becton, Dickinson and Company was awarded a $11,955.60 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to provide systems and reagents from its BD Biosciences division. Performance will take place in San Jose, California over a six-month period concluding in June 2024. The award was made using full and open competition procedures. No set-aside designations or subcontracting arrangements were specified....
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,258.95 firm fixed price Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases on June 14, 2018, with an ultimate completion date of July 31, 2018. The contract was awarded without a set-aside designation and will be performed in Bethesda, Maryland. As a global medical technology manufacturer specializing in flow cytometry...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for $8,217.50. This Blanket Purchase Agreement (BPA) call was awarded on December 18, 2015, with a completion date of December 31, 2015, utilizing firm fixed-price pricing. The contract involved no small business set-aside designation and was performed in Bethesda, Maryland. As a child entity...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $21,587.40 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The contract was awarded on February 8, 2019, with an ultimate completion date of July 31, 2019, for performance at the NIH campus in Bethesda, Maryland. No small business set-aside was...